GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Magnasense AB (OSTO:MAGNA) » Definitions » Debt-to-Equity

Magnasense AB (OSTO:MAGNA) Debt-to-Equity : -1.14 (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Magnasense AB Debt-to-Equity?

Magnasense AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was kr5.40 Mil. Magnasense AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was kr38.60 Mil. Magnasense AB's Total Stockholders Equity for the quarter that ended in Dec. 2024 was kr-38.65 Mil. Magnasense AB's debt to equity for the quarter that ended in Dec. 2024 was -1.14.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Magnasense AB's Debt-to-Equity or its related term are showing as below:

OSTO:MAGNA' s Debt-to-Equity Range Over the Past 10 Years
Min: -22.52   Med: 0   Max: 0.18
Current: -1.14

During the past 6 years, the highest Debt-to-Equity Ratio of Magnasense AB was 0.18. The lowest was -22.52. And the median was 0.00.

OSTO:MAGNA's Debt-to-Equity is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 0.21 vs OSTO:MAGNA: -1.14

Magnasense AB Debt-to-Equity Historical Data

The historical data trend for Magnasense AB's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Magnasense AB Debt-to-Equity Chart

Magnasense AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Equity
Get a 7-Day Free Trial 0.02 - 0.18 -22.52 -1.14

Magnasense AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -22.52 -3.52 -3.14 -2.11 -1.14

Competitive Comparison of Magnasense AB's Debt-to-Equity

For the Medical Devices subindustry, Magnasense AB's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Magnasense AB's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Magnasense AB's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Magnasense AB's Debt-to-Equity falls into.


;
;

Magnasense AB Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Magnasense AB's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Magnasense AB's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Magnasense AB  (OSTO:MAGNA) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Magnasense AB Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Magnasense AB's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Magnasense AB Business Description

Traded in Other Exchanges
Address
Scheelevagen 27, Lund, SWE, SE-223 63
AegirBio AB is a Swedish diagnostic company, specializes in developing a home testing platform for oral health, therapeutic drug monitoring and infectious diseases. The current product line up includes the Veritope technology, featuring intact natalizumab in MS, along with the MagniaReader designed for both research and veterinary applications.

Magnasense AB Headlines

No Headlines